Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyChristine E. Brown, Behnam Badie, Julie R. Ostberg et al.|New England Journal of Medicine|2016Cited by 1.8k
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory PhenotypeDarya Alizadeh, Christine E. Brown, Robyn A. Wong et al.|Cancer Immunology Research|2019Cited by 437
CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based TherapiesDongrui Wang, Jeremy N. Rich, Briana C. Prager et al.|Cancer Discovery|2020Cited by 177